S
Sarah Dysart
Publications - 3
Citations - 198
Sarah Dysart is an academic researcher. The author has contributed to research in topics: Cancer & Small interfering RNA. The author has an hindex of 2, co-authored 3 publications receiving 173 citations.
Papers
More filters
Journal ArticleDOI
A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer.
Andrea L. Kasinski,Kevin Kelnar,Carlos Stahlhut,Esteban A. Orellana,Jane Zhao,Eliot Shimer,Sarah Dysart,Xiaowei Chen,Andreas G. Bader,Frank J. Slack +9 more
TL;DR: This combinatorial miRNA therapeutic approach engages numerous components of tumor cell-addictive pathways and highlights the ability to deliver multiple miRNAs in a safe and effective manner to target lung tissue.
Proceedings ArticleDOI
Abstract C142: The development of a miRNA-based therapeutic candidate for hepatocellular carcinoma.
Chris Daige,Leslie Priddy,Kevin Kelnar,Jane Zhao,Sarah Dysart,Andreas G. Bader,David R. Brown +6 more
TL;DR: Five tumor suppressor miRNAs with the capacity to significantly inhibit the proliferation of multiple HCC cell lines were identified and injected into NOD/SCID mice with orthotopically grown Hep3B liver cancer xenografts.
Proceedings ArticleDOI
Abstract 5636: Preclinical data of a microRNA-based therapy for hepatocellular carcinoma
Andreas G. Bader,Christopher L. Daige,Kevin Kelnar,Leslie Priddy,Sarah Dysart,Jason F. Wiggins,Jane Zhao,Neil Leatherbury,Michael Omotola,Jay Stoudemire,Paul Lammers,David R. Brown +11 more
TL;DR: The pharmacologic and pharmacodynamic parameters of miRNA mimics complexed in ionizable NOV340 liposomes in an orthotopic tumor model of hepatocellular carcinoma are presented and treatment of mice carrying existing tumors mimics led to significant tumor regression, prolonged survival and lacked notable drug-related side effects.